Surgical procedures after preoperative chemotherapy (PCT) in patients (P) with primary operable breast cancer (BC) in the multicenter geparduo-trial.

被引：0
|
作者：
Von Minckwitz, G
Petrich, S
Raab, G
Schütte, M
Hilfrich, J
Blohmer, JU
Gerber, B
Costa, SD
Eidtmann, H
Jackisch, C
Du Bois, A
Kaufmann, M
机构：
[1] Univ Hosp, Frankfurt, Germany
[2] Rot Kreuz Krankenhaus, Munich, Germany
[3] Bethesda Krankenhaus, Essen, Germany
[4] Henrietten Stift, Hannover, Germany
[5] Charite, Berlin, Germany
[6] Univ Hosp, Rostock, Germany
[7] Markus Krankenhaus, Frankfurt, Germany
[8] Univ Hosp, Kiel, Germany
[9] Univ Hosp, Munster, Germany
[10] Horst Schmidt Kliniken, Wiesbaden, Germany
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
352
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [31] Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer
    Boughey, Judy C.
    Peintinger, Florentia
    Meric-Bernstam, Funda
    Perry, Allison C.
    Hunt, Kelly K.
    Babiera, Gildy V.
    Singletary, S. E.
    Bedrosian, Isabelle
    Lucci, Anthony
    Buzdar, Aman U.
    Pusztai, Lajos
    Kuerer, Henry M.
    ANNALS OF SURGERY, 2006, 244 (03) : 464 - 470
  • [32] Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB trial)
    Guarneri, Valentina
    Frassoldati, Antonio
    Piacentini, Federico
    Jovic, Gordana
    Giovannelli, Simona
    Oliva, Cristina
    Conte, PierFranco
    CLINICAL BREAST CANCER, 2008, 8 (02) : 192 - 194
  • [33] European Cooperative Trial in Operable Breast Cancer II (ECTO II): activity of primary chemotherapy in ER negative early breast cancer
    Zambetti, M.
    Pascoletti, G.
    Gomez, P.
    Semiglazov, V.
    Lluch, A.
    De Benedictis, E.
    Ojeda, B.
    Dittrich, C.
    Valagussa, P.
    Gianni, L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 302 - 302
  • [34] Surgery after primary systemic chemotherapy in patients with breast cancer
    Eiermann, Wolfgang
    Ataseven, Beyhan
    BREAST CARE, 2006, 1 (06) : 358 - 361
  • [35] Meta-analysis of sentinel lymph node biopsy following preoperative chemotherapy in patients with operable breast cancer
    Xing, Y
    Ding, M
    Cox, D
    Ross, MI
    Hunt, KK
    Cormier, JN
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 17S - 17S
  • [36] HMGA2 expression and response to anthracycline-based preoperative chemotherapy in patients with operable breast cancer
    Puglisi, F.
    Ermacora, P.
    Driol, P.
    Masolini, P.
    Alessi, B.
    Pisa, F. E.
    Pandolfi, M.
    Mansutti, M.
    Giancotti, V.
    Di Loreto, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] RANDOMIZED STUDY OF PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER - PRELIMINARY-RESULTS WITH 170 BREAST-CANCER PATIENTS
    DURAND, M
    MAURIAC, L
    PIGNEUX, J
    AVRIL, A
    DILHUYDY, JM
    MAREE, D
    BULLETIN DU CANCER, 1988, 75 (07) : 656 - &
  • [38] Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design
    Alvarez, Ricardo H.
    Hortobagyi, Gabriel N.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 701 - 705
  • [39] Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design
    Ricardo H. Alvarez
    Gabriel N. Hortobagyi
    Breast Cancer Research and Treatment, 2010, 124 : 701 - 705
  • [40] Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
    J-Y Pierga
    E Mouret
    V Diéras
    V Laurence
    P Beuzeboc
    T Dorval
    T Palangié
    M Jouve
    A Vincent-Salomon
    S Scholl
    J-M Extra
    B Asselain
    P Pouillart
    British Journal of Cancer, 2000, 83 : 1480 - 1487
12345